Research programme: midkine therapeutics - Cell Signals
Alternative Names: midkine inhibitorsLatest Information Update: 16 Jul 2016
At a glance
- Originator Cell Signals
- Class Diagnostic agents
- Mechanism of Action Apoptosis inhibitors; Cytokine inhibitors; Diagnostic imaging enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Autoimmune disorders; Cancer; Heart failure; Post-surgical adhesions; Renal failure
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Autoimmune-disorders in Japan
- 16 Jul 2016 No recent reports of development identified for preclinical development in Cancer(Diagnosis) in Japan
- 16 Jul 2016 No recent reports of development identified for preclinical development in Heart-failure in Japan